Skip to main content
Equibles

Invesco Ltd.

Position in OCGN — Ocugen, Inc.

CIK 914208 Atlanta, GA
Back to OCGN Full portfolio

Position in OCGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$280,948
+$207,499 QoQ
Shares Held
183,628
+307.5% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 147 holders
Holding Since
Jun 2021
17 quarters on record
Voting authority Sole 0% Shared 95% None 5%

Common Shares in OCGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. OCGN ranks #222 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 8,043,052 $3,995,225,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,940,665 $2,457,162,245
3 ALNY
Alnylam Pharmaceuticals, Inc.
 3,754,318 $1,130,162,341
4 INCY
Incyte Corp
 4,080,461 $462,561,050
5 ARGX
Argenx SE
 443,990 $411,920,598
6 AXSM
Axsome Therapeutics, Inc.
 1,671,684 $409,178,086
7 MRNA
Moderna, Inc.
 5,780,299 $404,794,337
8 LGND
Ligand Pharmaceuticals Inc
 1,201,644 $379,827,645

All Filings in OCGN

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $280,948 183,628
2025-09-30 $73,449 45,061
2025-06-30 $43,409 44,752
2025-03-31 $133,205 188,678
2024-12-31 $139,709 173,553
2024-09-30 $123,874 124,874
2024-06-30 $191,385 123,475
2023-09-30 $30,718 76,797
2023-06-30 $39,774 73,249
2023-03-31 $65,353 76,616
2022-12-31 $108,472 83,441
2022-09-30 $164,029 92,152
2022-06-30 $185,047 81,519
2022-03-31 $259,749 78,712
2021-12-31 $367,639 80,800
2021-09-30 $758,925 105,700
2021-06-30 $675,651 84,141